Identifying Blood Transcriptome Biomarkers of Alzheimer’s Disease Using Transgenic Mice

The testing of pathological biomarkers of Alzheimer’s disease (AD), such as amyloid beta and tau, is time-consuming, expensive, and invasive. Here, we used 3xTg-AD mice to identify and validate putative novel blood transcriptome biomarkers of AD that can potentially be identified in the blood of pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ochi, Shinichiro, Iga, Jun-ichi, Funahashi, Yu, Yoshino, Yuta, Yamazaki, Kiyohiro, Kumon, Hiroshi, Mori, Hiroaki, Ozaki, Yuki, Mori, Takaaki, Ueno, Shu-ichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541363/
https://www.ncbi.nlm.nih.gov/pubmed/32816243
http://dx.doi.org/10.1007/s12035-020-02058-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541363/
https://www.ncbi.nlm.nih.gov/pubmed/32816243
http://dx.doi.org/10.1007/s12035-020-02058-2

Ejemplares similares